Back to LLY Stock Lookup

Eli Lilly & Co. (LLY) – StreetInsider.com Reports

Jan 20, 2017 06:59 AM Eli Lilly (LLY) PT Raised to $93 at Jefferies
Jan 18, 2017 09:23 AM Pre-Open Stock Movers 01/18: (CLCD) (SHLO) (JAZZ) Higher; (GIMO) (TGT) (CSX) Lower (more...)
Jan 18, 2017 06:47 AM Eli Lilly (LLY) to Acquire CoLucid Pharmaceuticals (CLCD) for $960M
Jan 18, 2017 06:04 AM Goldman Sachs Raises Eli Lilly (LLY) PT, Sees Catalysts In Coming Year, Maintains Conviction Buy
Jan 17, 2017 07:20 AM Eli Lilly & Co. (LLY), Incyte (INCY) Announce FDA Extends Review Period for Baricitinib
Jan 11, 2017 06:50 AM Eli Lilly & Co. (LLY) Expands Immuno-Oncology Collaboration with Merck (MRK)
Jan 5, 2017 03:23 PM Eli Lilly & Co. (NYSE: LLY) calls active after sharp four-week rally
Jan 5, 2017 03:14 PM Eli Lilly & Co. (LLY) Active, Shares Gain
Jan 4, 2017 05:12 PM Lilly & Co. (LLY) and Boehringer Ingelheim Report FDA Approves sNDAs to Include Data in Product Labels for Synjardy, Synjardy XR, and Glyxambi
Jan 4, 2017 06:40 AM Goldman Expects Oncology M&A To Be Active In 2017, Sees (GILD), (JNJ), (PFE), (MRK), (NVS), (SNY), (LLY) As Possible Acquirers
Dec 30, 2016 04:57 AM Volatility as an asset class
Dec 23, 2016 04:56 AM Stocks with Implied Volatility Movement
Dec 21, 2016 04:53 AM Stocks with Implied Volatility Movement
Dec 20, 2016 07:59 AM Eli Lilly (LLY) Removed from Credit Suisse U.S Focus List
Dec 16, 2016 04:26 PM Incyte (INCY), Eli Lilly (LLY) Amend Baricitinib Agreement
Dec 16, 2016 02:09 PM Eli Lilly & Co. (LLY), Boehringer Ingelheim Annouces New Jardiance Recommendation from ADA
Dec 16, 2016 12:03 PM Adocia and Lilly (LLY) Successfuly Complete BioChaperone Lispro Insulin Pump Study
Dec 16, 2016 07:50 AM Eli Lilly & Co. (LLY), Incyte (INCY) Announce CHMP Recommendation of Baricitinib for Adults with RA
Dec 16, 2016 06:42 AM Morgan Stanley Upgrades Eli Lilly (LLY) to Overweight
Dec 15, 2016 11:35 AM Goldman Sachs Adds Eli Lilly (LLY) to Conviction Buy List
Dec 15, 2016 09:26 AM Pre-Open Stock Movers 12/15: (CBIO) (ATHN) (PIR) (IDCC) Higher; (ORIG) (SGY) (PACB) Lower (more...)
Dec 15, 2016 07:03 AM Eli Lilly & Co. (LLY) Announces BASAGLAR Insulin Now Available in U.S.
Dec 15, 2016 06:27 AM Eli Lilly & Co. (LLY) Sees FY17 Adj. EPS of $4.05-$4.15, Versus $3.97 Consensus
Dec 14, 2016 07:06 AM Eli Lilly & Co. (LLY) Could Surprise to the Downside - BMO
Dec 13, 2016 06:32 AM Eli Lilly & Co. (LLY) Announces Discounted Insulin Starting January 1st
Dec 12, 2016 06:01 PM Eli Lilly & Co. (LLY) Raises Quarterly Dividend 2% to $0.52; 3.1% Yield
Dec 12, 2016 03:29 PM Eli Lilly & Co. (LLY) Announces FDA Approval for Synjardy for Adults with Type 2 Diabetes
Dec 12, 2016 08:23 AM Biogen (BIIB): Two Reasons To Be Positive On Alzheimers Treatments - HC Wainwright
Dec 9, 2016 07:02 AM Eli Lilly & Co. (LLY), AstraZeneca (AZN) to Co-Develop MEDI181 for Alzheimer's
Dec 9, 2016 05:46 AM Eli Lilly & Co. (LLY) Details Results from Phase 3 EXPEDITION3 Trial, Which Missed Primary Endpoint in AD
Dec 8, 2016 08:33 AM Eli Lilly & Co. (LLY) Announces Abemaciclib neoMONARCH Phase 2 Met Primary Endpoint
Dec 6, 2016 07:05 AM Trump's corporate tax holiday could spur pharma M&A
Dec 5, 2016 08:07 AM Eli Lilly & Co. (LLY) Confirms FDA Approves Jardiance to Reduce CV Death in Adults with Type 2 Diabetes and CV Disease
Dec 2, 2016 01:11 PM FDA Approves Boehringer Ingelheim's Jardiance to Reduce Cardiovascular Death in Adults with Type 2 Diabetes (LLY)
Nov 28, 2016 07:45 AM Eli Lilly & Co. (LLY) Removed from US 1 List at BofA/ML
Nov 25, 2016 05:36 AM Options with increasing call volume on November 23; GFI PIR BYD ON UIS IEF LLY
Nov 23, 2016 02:58 PM Eli Lilly & Co. (LLY) volatility and share price pullback after Alzheimer's data
Nov 23, 2016 02:57 PM Eli Lilly (LLY) PT Cut to $92 at Leerink Partners
Nov 23, 2016 01:48 PM BMO Capital Downgrades Eli Lilly (LLY) to Market Perform Following Sola's Failure
Nov 23, 2016 12:30 PM Streetinsider.com's Hot Lunchtime Reads 11/23: (JUNO) (AMZN) (AXON) (LLY)
Nov 23, 2016 11:47 AM Eli Lilly & Co. (LLY) 30-day call option implied volatility is at 66, compared to a one month ago level of 24.
Nov 23, 2016 11:41 AM Lilly's (LLY) Solanezumab Phase 3 Miss is Credit-Negative Event - Moody's
Nov 23, 2016 09:51 AM Options with increasing volume: BYD LLY VRX CELG URBN CTRP HPQ DE GME MU
Nov 23, 2016 09:50 AM Neurotrope (NTRP) Comments on Results from Lilly's (LLY) Solanezumab Phase 3 in Alzheimer's disease
Nov 23, 2016 09:24 AM Pre-Open Stock Movers 11/23: (MDGS) (VEEV) (BLXT) Higher; (JUNO) (LLY) (URBN) Lower (more...)
Nov 23, 2016 07:57 AM Eli Lilly Sola Failure is a 'Serious Blow' to Biogen (BIIB) and Others in AD Field - Leerink
Nov 23, 2016 07:50 AM Axovant Sciences (AXON) Sinks 17% on Eli Lilly Sola Failure
Nov 23, 2016 07:48 AM Eli Lilly & Co. (LLY) AD Portfolio Uncertain Following Sola Failure - Leerink
Nov 23, 2016 07:33 AM Dow, S&P 500 set record high closes ahead of holiday
Nov 23, 2016 07:22 AM Eli Lilly & Co. (LLY) CEO Lechleite Not Concerned About Dividend - CNBC

Back to LLY Stock Lookup